A significant advance in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial cancer protector protein is frequently lost in various kinds of cancer, causing https://thesocialintro.com/story7639246/mini-antibodies-restore-tumor-suppressor-p53-the-new-pathway-for-malignant-management